Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Inhibiting the enzyme pharmacologically aims to reproduce that effect, which is why multiple independent NNMT inhibitors have been developed
The TRANSCEND-T2D-1 trial (NCT06354660) demonstrated HbA1c reductions of 1.7-2.0% and 36.6 lbs mean weight loss in type 2 diabetes participants over 40 weeks
PMID:10952480 Peter C et al
Technical Specifications Total Mass : 20mg Components : BPC-157 and TB-500 Form : Co-lyophilized powder COA : Provided (batch-specific HPLC and MS data) Storage & Handling Store lyophilized at 20C for long-term stability
US$ 23.61
US$ 27.92
US$ 21.26
US$ 27.22
US$ 25.43
US$ 28.73
